Cite

HARVARD Citation

    Murthy, R. et al. (2014). Effect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2‐positive metastatic breast cancer. Cancer. 120 (13), pp. 1932-1938. [Online]. 
  
Back to record